MedPath

Comparison of the Sodium valproate and Sodae herbal capsule side effects in migraine patients

Phase 3
Conditions
Migraine.
Other disorders of nervous system
G98.8
Registration Number
IRCT20200126046272N2
Lead Sponsor
Kermanshah University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
90
Inclusion Criteria

Having more than 3 attacks per month in the last three months
Having more than 3 attacks at the base time
Start migraines at least one year before entering the project
Start migraines before age 50

Exclusion Criteria

Chronic tension headaches or other headaches for more than 15 days a month
Pregnancy, lactation
Patients should not be addicted to alcohol or other illegal substances

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Side effects. Timepoint: Baseline, Three months after the Baseline. Method of measurement: Record the side effects that the patient reports, Laboratory tests of people's blood samples.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath